• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

南非药物不良反应报告的完整性:VigiBase®中的分析。

The completeness of adverse drug reaction reports in South Africa: An analysis in VigiBase®.

机构信息

Medicine Usage in South Africa, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa; and Pharmacovigilance Unit, South African Health Products Regulatory Authority, Pretoria.

出版信息

Afr J Prim Health Care Fam Med. 2023 Jan 18;15(1):e1-e9. doi: 10.4102/phcfm.v15i1.3659.

DOI:10.4102/phcfm.v15i1.3659
PMID:36744452
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9900287/
Abstract

BACKGROUND

Spontaneous reporting is regarded as a cornerstone of pharmacovigilance (PV) but presents many limitations, including varying quality and completeness of information, which is essential for causality assessment.

AIM

This study aimed to evaluate the completeness of adverse drug reaction (ADR) reports in South Africa based on the vigiGrade completeness score.

SETTING

The South African Health Products Regulatory Authority (SAHPRA).

METHODS

A cross-sectional, descriptive study of all reports received by SAHPRA and submitted to VigiBase® in 2017 was conducted. A report with a vigiGrade score 0.8 is considered well-documented.

RESULTS

The mean completeness score for the 8438 reports received was 0.456 (s.d. = 0.221). Only 11.3% of reports had a completeness score 0.8. The completeness of reports submitted by consumers professionals did not significantly differ from reports by physicians, pharmacists or other healthcare professionals (d ≤ 0.2). Reports of reactions that resulted in death (M = 0.572, s.e. = 0.007), disability (M = 0.491, s.e. 0.033) or were life threatening (M = 0.474, s.e. = 0.013) had a medium to large practically significant effect (0.5 ≥ d ≤ 0.8) on the completeness score compared with reports of congenital anomaly (M = 0.348, s.e. = 0.089).

CONCLUSION

The completeness of reports submitted by consumers is comparable to those submitted by healthcare professionals. The completeness of reports was low and multiple measures to improve reporting are recommended.Contribution: This study describes the completeness of ADR reports in South Africa and the results can be used to improve training.

摘要

背景

自发报告被视为药物警戒(PV)的基石,但存在许多局限性,包括信息的质量和完整性各不相同,这对于因果关系评估至关重要。

目的

本研究旨在根据 vigiGrade 完整性评分评估南非不良药物反应(ADR)报告的完整性。

设置

南非卫生产品监管局(SAHPRA)。

方法

对 2017 年由 SAHPRA 收到并提交给 VigiBase®的所有报告进行了一项横断面、描述性研究。 vigiGrade 得分为 0.8 的报告被认为记录完整。

结果

收到的 8438 份报告的平均完整性评分为 0.456(标准差=0.221)。只有 11.3%的报告完整性评分为 0.8。消费者专业人员提交的报告的完整性与医生、药剂师或其他医疗保健专业人员提交的报告没有显著差异(d ≤ 0.2)。导致死亡(M = 0.572,标准误=0.007)、残疾(M = 0.491,标准误 0.033)或危及生命(M = 0.474,标准误=0.013)的反应报告的完整性评分与先天性异常报告(M = 0.348,标准误 0.089)相比具有中等至较大的实际显著影响(0.5≥d≤0.8)。

结论

消费者提交的报告的完整性与医疗保健专业人员提交的报告相当。报告的完整性较低,建议采取多项措施提高报告质量。

贡献

本研究描述了南非 ADR 报告的完整性,研究结果可用于改进培训。

相似文献

1
The completeness of adverse drug reaction reports in South Africa: An analysis in VigiBase®.南非药物不良反应报告的完整性:VigiBase®中的分析。
Afr J Prim Health Care Fam Med. 2023 Jan 18;15(1):e1-e9. doi: 10.4102/phcfm.v15i1.3659.
2
Profile of adverse drug reaction reports in South Africa: An analysis of VigiBase® for the year 2017.南非药物不良反应报告概况:对 2017 年 VigiBase® 的分析。
S Afr Med J. 2023 Jun 5;113(6):26-33. doi: 10.7196/SAMJ.2023.v113i5.16522.
3
Evaluation of completeness of suspected adverse drug reaction reports submitted to the mexican national pharmacovigilance centre: a cross-sectional period-prevalence study.评价向墨西哥国家药物警戒中心报告的疑似药物不良反应报告的完整性:一项横断面时期患病率研究。
Drug Saf. 2012 Oct 1;35(10):837-44. doi: 10.1007/BF03261979.
4
Comparative Analysis of Information Provided in German Adverse Drug Reaction Reports Sent by Physicians, Pharmacists and Consumers.德国医生、药师和消费者上报的药品不良反应报告中信息的比较分析。
Drug Saf. 2023 Dec;46(12):1363-1379. doi: 10.1007/s40264-023-01355-8. Epub 2023 Nov 21.
5
vigiGrade: a tool to identify well-documented individual case reports and highlight systematic data quality issues.vigiGrade:一种用于识别记录完善的个例报告并突出系统数据质量问题的工具。
Drug Saf. 2014 Jan;37(1):65-77. doi: 10.1007/s40264-013-0131-x.
6
Knowledge, attitudes and perspective on adverse drug reaction reporting in a public sector hospital in South Africa: baseline analysis.南非一家公立医院中关于药品不良反应报告的知识、态度及观点:基线分析
Hosp Pract (1995). 2017 Dec;45(5):238-245. doi: 10.1080/21548331.2017.1381013. Epub 2017 Sep 27.
7
Exploring Completeness of Adverse Event Reports as a Tool for Signal Detection in Pharmacovigilance.探索不良事件报告的完整性作为药物警戒信号检测工具。
Ther Innov Regul Sci. 2021 Jan;55(1):142-151. doi: 10.1007/s43441-020-00199-z. Epub 2020 Jul 27.
8
Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study.全科医生向地区药物警戒中心发送的自发药品不良反应报告的完整性:一项描述性研究。
Drug Saf. 2016 Dec;39(12):1189-1195. doi: 10.1007/s40264-016-0463-4.
9
Trends in Adverse Event Reporting Before and After the Introduction of the Med Safety App in Nigeria.尼日利亚引入 Med Safety 应用前后不良事件报告趋势。
Pharmaceut Med. 2024 May;38(3):251-259. doi: 10.1007/s40290-024-00524-z. Epub 2024 May 6.
10
Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi.通过培训和指导加强撒哈拉以南非洲的药物警戒:GSK 在马拉维的试点计划。
Drug Saf. 2020 Jun;43(6):583-593. doi: 10.1007/s40264-020-00925-4.

引用本文的文献

1
Comparison of the Completeness of Spontaneously Reported Adverse Drug Reactions by Consumers, Healthcare Professionals, and Pharmaceutical Companies: An Evaluation of Databases From Two High-Income Countries.消费者、医疗保健专业人员和制药公司自发报告的药品不良反应完整性比较:对两个高收入国家数据库的评估
Pharmacol Res Perspect. 2025 Aug;13(4):e70164. doi: 10.1002/prp2.70164.
2
Awareness and Attitudes Regarding Adverse Drug Events and Reporting in South Africa.南非对药物不良事件及报告的认知与态度
Ther Innov Regul Sci. 2025 May 13. doi: 10.1007/s43441-025-00795-x.
3
Disponibilité de l'information médicale requise pour la déclaration d'une réaction indésirable médicamenteuse à Santé Canada: une étude exploratoire.向加拿大卫生部报告药物不良反应所需医学信息的可获取性:一项探索性研究。
Can J Hosp Pharm. 2024 Feb 14;77(1):e3489. doi: 10.4212/cjhp.3489. eCollection 2024.
4
The Case for Pre-Emptive Pharmacogenetic Screening in South Africa.南非进行先发制药物遗传学筛查的理由。
J Pers Med. 2024 Jan 19;14(1):114. doi: 10.3390/jpm14010114.
5
Comparative Analysis of Information Provided in German Adverse Drug Reaction Reports Sent by Physicians, Pharmacists and Consumers.德国医生、药师和消费者上报的药品不良反应报告中信息的比较分析。
Drug Saf. 2023 Dec;46(12):1363-1379. doi: 10.1007/s40264-023-01355-8. Epub 2023 Nov 21.

本文引用的文献

1
The quality assessment of the Japanese Adverse Drug Event Report database using vigiGrade.使用 vigiGrade 评估日本药品不良反应报告数据库的质量。
Int J Clin Pharm. 2020 Apr;42(2):728-736. doi: 10.1007/s11096-020-00969-7. Epub 2020 Feb 4.
2
Electronic health record system in the public health care sector of South Africa: A systematic literature review.南非公共卫生保健部门的电子健康记录系统:一项系统文献综述。
Afr J Prim Health Care Fam Med. 2018 Nov 20;10(1):e1-e8. doi: 10.4102/phcfm.v10i1.1746.
3
An analysis of completeness and quality of adverse drug reaction reports at an adverse drug reaction monitoring centre in Western India.印度西部一家药品不良反应监测中心的药品不良反应报告完整性及质量分析
Perspect Clin Res. 2018 Jul-Sep;9(3):123-126. doi: 10.4103/picr.PICR_105_17.
4
Causality or Relatedness Assessment in Adverse Drug Reaction and Its Relevance in Dermatology.药物不良反应中的因果关系或相关性评估及其在皮肤病学中的意义
Indian J Dermatol. 2018 Jan-Feb;63(1):18-21. doi: 10.4103/ijd.IJD_579_17.
5
The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis.患者和医疗保健专业人员提交的药品不良反应报告中的临床信息质量:一项回顾性比较分析
Drug Saf. 2017 Jul;40(7):607-614. doi: 10.1007/s40264-017-0530-5.
6
Lack of essential information in spontaneous reports of adverse drug reactions in Catalonia-a restraint to the potentiality for signal detection.加泰罗尼亚药物不良反应自发报告中缺乏关键信息——对信号检测潜力的一种限制。
Eur J Clin Pharmacol. 2017 Jun;73(6):751-758. doi: 10.1007/s00228-017-2223-5. Epub 2017 Mar 1.
7
Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study.全科医生向地区药物警戒中心发送的自发药品不良反应报告的完整性:一项描述性研究。
Drug Saf. 2016 Dec;39(12):1189-1195. doi: 10.1007/s40264-016-0463-4.
8
Completeness of adverse drug reactions reports of the Saudi adverse event reporting system.沙特药品不良反应报告系统中不良事件报告的完整性
Saudi Med J. 2015 Jul;36(7):821-8. doi: 10.15537/smj.2015.7.11751.
9
Strengthening pharmacovigilance in South Africa.加强南非的药物警戒。
S Afr Med J. 2014 Feb;104(2):104-6. doi: 10.7196/samj.7517.
10
vigiGrade: a tool to identify well-documented individual case reports and highlight systematic data quality issues.vigiGrade:一种用于识别记录完善的个例报告并突出系统数据质量问题的工具。
Drug Saf. 2014 Jan;37(1):65-77. doi: 10.1007/s40264-013-0131-x.